血清高密度脂蛋白胆固醇与新发胆石症的关系

孙苗苗; 曹立瀛; 孙卫东; 刘希宁; 崔皓哲; 梁明扬; 魏垚臣; 王万超; 刘四清

doi:10.3969/j.issn.1001-5256.2019.08.019

血清高密度脂蛋白胆固醇与新发胆石症的关系

DOI: 10.3969/j.issn.1001-5256.2019.08.019

华北理工大学研究生院
华北理工大学附属开滦总医院肝胆外科
滦南县医院外四科

基金项目:

河北省卫生和计划生育委员会重点科技研究计划(20171435)；

详细信息

中图分类号: R575.62
计量
- 文章访问数: 1232
- HTML全文浏览量: 17
- PDF下载量: 265
- 被引次数: 0
出版历程
- 收稿日期: 2019-03-27
- 出版日期: 2019-08-20

Association of serum high-density lipoprotein cholesterol with new-onset cholelithiasis

Graduate School of North China University of Science and Technology

Research funding:

摘要

摘要: 目的探讨血清高密度脂蛋白胆固醇（HDL-C）水平对新发胆石症的影响。方法采用前瞻性队列研究的方法,收集2006年7月-2015年12月开滦集团健康体检的在职及离退休职工87 891人的体检资料,并纳入统计分析。正态分布的计量资料多组间比较采用单因素方差分析,偏态分布的计量资料多组间比较采用Kruskal-Wallis H检验,计数资料组间比较采用χ2检验。将观察对象依据HDL-C四分位数分为4组,计算各组胆石症的发病密度,采用寿命表法计算各组胆石症的累积发病率,并采用log-rank检验比较组间差异;采用Cox回归模型分析不同HDL-C水平对新发胆石症的影响。结果 4组观察对象的临床特征比较:性别、年龄、BMI、LDL-C、HDL-C、FBG、hs-CRP、TG、TC、高血压病、糖尿病、饮酒、吸烟及体育锻炼比例差异均有统计学意义（P值均<0. 05）。在平均（8. 19±0. 85）年的随访期间,新发胆石症2881例,各组的胆石症发病密度分别为4. 36/千人年、3. 81/千人年、3. 96/千人年、3. 90/千人年,各组的累积发病率分别为6. 49%、6. 01%、6. 3...
- 胆结石 /
- 胆固醇,HDL /
- 危险因素 /
- 队列研究
Abstract: Objective To investigate the influence of serum high-density lipoprotein cholesterol (HDL-C) level on new-onset cholelithiasis. Methods A prospective cohort study was conducted. The physical examination data of 87 891 on-the-job and retired workers in Kailuan Group were collected from July 2006 to December 2015 and were included in the statistical analysis. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, the Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution between multiple groups, and the chi-square test was used for comparison of categorical data between groups. The subjects were divided into four groups according to HDL-C quartiles, and the incidence density of cholelithiasis was calculated for each group. The life-table method was used to calculate the cumulative incidence rate of cholelithiasis in each group, the log-rank test was used for comparison between groups, and the Cox regression model was used to analyze the influence of HDL-C level on new-onset cholelithiasis. Results There were significant differences between the four groups in sex, age, body mass index, low-density lipoprotein cholesterol, HDL-C, fasting blood glucose, high-sensitivity C-reactive protein, triglyceride, total cholesterol, hypertension, diabetes, drinking, smoking, and physical exercise (all P < 0. 05) . During the mean follow-up time of 8. 19 ± 0. 85 years, a total of 2881 cases of new-onset cholelithiasis were observed, and the incidence density of cholelithiasis in the four groups was 4. 36 per 1000 person-years, 3. 81 per 1000 person-years, 3. 96 per 1000 person-years, and 3. 90 per 1000 person-years, respectively. The cumulative incidence rates in the four groups were 6. 49%, 6. 01%, 6. 36%, and 6. 16%, respectively, and the log-rank test showed a significant difference between groups (χ2= 25. 34, P < 0. 05) . In the Cox proportional hazards regression model, after the adjustment for possible confounding factors, the results showed that compared with the first quartile group of HDL-C, the second, third, and fourth quartile groups had hazard ratios (95% confidence interval) for gallstone disease of 0. 84 (0. 75-0. 93) , 0. 86 (0. 78-0. 96) , and 0. 78 (0. 70-0. 86) , respectively (P for trend < 0. 05) . Conclusion A high serum level of HDL-C is an independent protective factor against new-onset chole-lithiasis, and the risk of cholelithiasis decreases with the increase in HDL-C.
- cholelithiasis /
- cholesterol, HDL /
- risk factors /
- cohort study

HTML全文

参考文献(28)

[1] STINTON LM, SHAFFER EA. Epidemiology of gallbladder disease:Cholelithiasis and cancer[J]. Gut Liver, 2012, 6 (2) :172-187.

[2] GLAMBEK I, KVAALE G, ARNESJB, et al. Prevalence of gallstones in a Norwegian population[J]. Scand J Gastroenterol, 1987, 22 (9) :1089-1094.

[3] EVERHART JE, KHARE M, HILL M, et al. Prevalence and ethnic differences in gallbladder disease in the United States[J].Gastroenterology, 1999, 117 (3) :632-639.

[4] KHUROO MS, MAHAJAN R, ZARGAR SA, et al. Prevalence of biliary tract disease in India:A sonographic study in adult population in Kashmir[J]. Gut, 1989, 30 (2) :201-205.

[5] NOMURA H, KASHIWAGI S, HAYASHI J, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan[J]. Am J Epidemiol, 1988, 128 (3) :598-605.

[6] PORTINCASA P, MOSCHETTA A, PALASCIANO G. Cholesterol gallstone disease[J]. Lancet, 2006, 368 (9531) :230-239.

[7] ABOU-SAIF A, AL-KAWAS FH. Complications of gallstone disease:Mirizzi syndrome, cholecystocholedochal fistula, and gallstone ileus[J]. Am J Gastroenterol, 2002, 97 (2) :249-254.

[8] PORTINCASA P, DI CIAULA A, de BARI O, et al. Management of gallstones and its related complications[J]. Expert Rev Gastroenterol Hepatol, 2016, 10 (1) :93-112.

[9] BARBARA L, SAMA C, MORSELLI LABATE AM, et al. A population study on the prevalence of gallstone disease:The sirmione study[J]. Hepatology, 1987, 7 (5) :913-917.

[10] LEE YC, WU JS, YANG YC, et al. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease[J]. Scand J Gastroenterol, 2014, 49 (8) :1001-1006.

[11] HUNG SC, LIAO KF, LAI SW, et al. Risk factors associated with symptomatic cholelithiasis in Taiwan:A populationbased study[J]. BMC Gastroenterol, 2011, 11:111.

[12] The epidemiology of gallstone disease in Rome, Italy. Part II.Factors associated with the disease[J]. Hepatology, 1988, 8 (4) :907-913.

[13] HALLDESTAM I, KULLMAN E, BORCH K. Incidence of and potential risk factors for gallstone disease in a general population sample[J]. Br J Surg, 2010, 96 (11) :1315-1322.

[14] LIN I, YANG YW, WU MF, et al. The association of metabolic syndrome and its factors with gallstone disease[J]. BMC Fam Pract, 2014, 15:138.

[15] CHEN CH, HUANG MH, YANG JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan:An epidemiological survey[J]. J Gastroenterol Hepatol, 2006, 21 (11) :1737-1743.

[16] BANIM PJ, LUBEN RN, BULLUCK H, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk) [J]. Eur J Gastroenterol Hepatol, 2011, 23 (8) :733-740.

[17] VLZKE H, BAUMEISTER SE, ALTE D, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence[J]. Digestion, 2005, 71 (2) :97-105.

[18] DAVIDE F, ADA D, SIMONA C, et al. Incidence of gallstone disease in Italy:Results from a multicenter, populationbased Italian study (the MICOL project) [J]. World J Gastroenterol, 2008, 14 (34) :5282-5289.

[19] WU SL, HUANG ZR, YANG XC, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city[J].Circ Cardiovasc Qual Outcomes, 2012, 5 (4) :487-493.

[20] Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension[J]. Chin J Cardiol, 2011, 39 (7) :579-616. (in Chinese) 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志, 2011, 39 (7) :579-616.

[21] Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition) [J]. Chin J Pract Intern Med, 2018, 38 (4) :292-344. (in Chinese) 中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2017年版) [J].中国实用内科杂志, 2018, 38 (4) :292-344.

[22] Joint committee issued Chinese guideline for the management of dyslipidemia. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chin Circulation J, 2016, 31 (10) :937-953. (in Chinese) 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南 (2016年修订版) [J].中国循环杂志, 2016, 31 (10) :937-953.

[23] LIU T, WANG YM, SI TF, et al. Predictive value of cumulative body mass index on new-onset cholelithiasis[J]. Chin J Dig Surg, 2017, 16 (2) :188-194. (in Chinese) 刘通, 王一鸣, 司天福, 等.累积体质量指数对新发胆石症的预测价值[J].中华消化外科杂志, 2017, 16 (2) :188-194.

[24] MISCIAGNA G, LEOCI C, GUERRA V, et al. The epidemiology of cholelithiasis in southern Italy[J]. Eur J Gastroenterol Hepatol, 1996, 8 (6) :585-593.

[25] JANOWITZ P, WECHSLER JG, KUHN K, et al. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones[J]. Clin Investig, 1992, 70 (5) :430-436.

[26] LAMBOU-GIANOUKOS S, HELLER SJ. Lithogenesis and bile metabolism[J]. Surg Clin North Am, 2008, 88 (6) :1175-1194.

[27] WINGRAVE SJ, KAY CR. Oral contraceptives and gallbladder disease[J]. Lancet, 1982, 2 (8305) :957-959.

[28] ABUESHY SA, MAHFOUZ AA, BADR A, et al. Prevalence and risk factors of gallstone disease in a high altitude Saudi population[J]. East Mediterr Health J, 2007, 13 (4) :794-802.

施引文献

资源附件(0)

访问统计